Natural History Study in Pediatric Patients with STXBP1 Encephalopathy with Epilepsy
NCT05462054 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2024-10-18
Summary
This is a prospective, non-interventional, longitudinal study designed to characterize the natural history of STXBP1 related encephalopathy with epilepsy, in participants ≤ \<5 years of age.
Conditions
- STXBP1 Encephalopathy with Epilepsy
Sponsors & Collaborators
-
Capsida Biotherapeutics, Inc.
lead INDUSTRY
Principal Investigators
-
Medical Monitor, MD · Capsida Biotherapeutics, Inc.
Eligibility
- Min Age
- 1 Day
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-31
- Primary Completion
- 2026-01-31
- Completion
- 2026-01-31
More Related Trials
-
Ultra High Field MRI of Focal Pediatric Epilepsy
NCT03318237 ·Status: TERMINATED
-
Compassionate Use of Stiripentol in Dravet Syndrome
NCT01835314 ·Status: NO_LONGER_AVAILABLE
-
Phase 1b Study of Tizanidine in Pediatric Patients With Cerebral Palsy
NCT01405950 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Prevent Infantile Spasms Relapse
NCT06819670 ·Status: RECRUITING ·Phase: PHASE2
-
Electroclinical Effect of Steroid in Patients With Benign Childhood Epilepsy With Centrotemporal Spikes
NCT03490487 ·Status: UNKNOWN ·Phase: PHASE4
-
Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies
NCT06700811 ·Status: RECRUITING ·Phase: PHASE1
-
A Novel Approach to Infantile Spasms
NCT03347526 ·Status: SUSPENDED ·Phase: PHASE3
-
Neurodevelopmental Outcome of Early Dietary Lysine Restriction in Pyridoxine Dependent Epilepsy Patients
NCT01795170 ·Status: WITHDRAWN
-
Epileptic Syndromes in Infants and Early Childhood
NCT06223334 ·Status: RECRUITING
-
GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome
NCT02224703 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Neuroinflammation in Children With Infantile Spasms
NCT02092883 ·Status: COMPLETED ·Phase: PHASE4
-
Valproic Acid-associated Hypoalbuminemia in Medically Fragile Patients
NCT00723762 ·Status: COMPLETED
-
The Prevalence and Risk Factors of Coagulopathy in Pediatric Epilepsy Surgery Patients
NCT05675254 ·Status: COMPLETED
-
The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy
NCT02815540 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)
NCT03848481 ·Status: TERMINATED ·Phase: PHASE2
-
Physical Excercise Program in Children With Drug-resistant Epilepsy
NCT05323682 ·Status: UNKNOWN ·Phase: NA
-
Management of Drug-resistant Epilepsy in Infants and Children: a Real-life Study of the Use of the Ketogenic Diet in France and the KetoCal® Range in Its Maintenance
NCT06075485 ·Status: RECRUITING
-
Evaluating Dietary Intervention Before surgicaL Treatment for Epilepsy
NCT02261753 ·Status: TERMINATED ·Phase: NA
-
RCT for Intermittent Versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies
NCT00515359 ·Status: COMPLETED ·Phase: NA
-
Erythropoietin Therapy for Children With Cerebral Palsy: Phase 1
NCT01586052 ·Status: COMPLETED ·Phase: PHASE1
-
Use of the Atkins Diet for Children With Sturge Weber Syndrome
NCT00639730 ·Status: COMPLETED ·Phase: PHASE1
-
Diabetic Ketoacidosis and Its Impact on the Brain
NCT01753934 ·Status: COMPLETED
-
Childhood Convulsive Status Epilepticus Management In A Resource Limited Setting
NCT03650270 ·Status: COMPLETED ·Phase: PHASE3
-
Open-label Extension to Protocol 1042-0500
NCT00442104 ·Status: TERMINATED ·Phase: PHASE2
-
Cannabinoid Therapy for Pediatric Epilepsy
NCT02983695 ·Status: COMPLETED ·Phase: PHASE1